Intensity Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INTS and other ETFs, options, and stocks.About INTS
Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine.
INTS Key Statistics
Stock Snapshot
The current Intensity Therapeutics(INTS) stock price is $7.76, with a market capitalization of 19.56M. The stock trades at a price-to-earnings (P/E) ratio of -0.49.
During the trading session on 2026-03-05, Intensity Therapeutics(INTS) shares reached a daily high of $7.79 and a low of $7.40. At a current price of $7.76, the stock is +4.9% higher than the low and still -0.3% under the high.
Trading volume for Intensity Therapeutics(INTS) stock has reached 19.82K, versus its average volume of 69.08K.
The stock's 52-week range extends from a low of $4.63 to a high of $62.49.
The stock's 52-week range extends from a low of $4.63 to a high of $62.49.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.